Can a 30-Minute online session spark quit motivation in smokers with chronic pain?

NCT ID NCT07743710

Recruiting now Symptom relief Sponsor: Binghamton University Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study aims to develop and test two short telehealth education sessions designed for people who smoke daily and live with chronic pain. The sessions provide information on how smoking affects health and where to find cessation resources. Researchers will first refine the materials with feedback from focus groups, then compare how feasible and acceptable each session is for participants. Volunteers will attend one online session and complete surveys over the following three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Smoking and Health Telehealth Intervention (educational session delivered via live telehealth)
What this could lead to: If successful, this could provide a practical, accessible telehealth option to help smokers with chronic pain become more motivated to quit.
What could go wrong: This is an early-stage feasibility study with a small number of participants, so it won't prove whether the intervention actually helps people quit smoking. Results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Tobacco Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOBACCO SMOKING

Contacts and locations

Locations

Binghamton University
RECRUITING

Binghamton, New York, 13905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.